Syngen Biotech Co (8279.TWO) Stock Price

Syngen Biotech Co Price

CLOSED
80.30
​
Market closed

Revenue has compounded at 22.3% per year over the past 25 years to 2.14 B TWD. Earnings per share have grown at 15.0% per year over the last 14 years. Syngen Biotech Co's net margin stands at 12.7%, down from 16.2% several years earlier. Syngen Biotech Co currently offers a dividend yield of about 6.23%. The payout ratio is around 50% of earnings. The dividend has grown at 7.7% per year over the past 3 years.

Syngen Biotech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syngen Biotech Co business model & stock analysis

Syngen Biotech Co., Ltd. generates revenue through the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. The company's portfolio includes active pharmaceutical ingredients, health food raw materials, and animal health products. Additionally, the firm offers medical equipment such as bone density analyzers, blood glucose analyzers, and biochemical analyzers to its customer base.

Frequently asked questions about Syngen Biotech Co

9 analysts currently rate the Syngen Biotech Co stock: 8 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Syngen Biotech Co share trades at 2.18 EUR (80.30 TWD).

The revenue cannot currently be calculated for Syngen Biotech Co.

The profit cannot currently be calculated for Syngen Biotech Co.

The P/E ratio cannot be calculated for Syngen Biotech Co at the moment.

The P/S cannot be calculated for Syngen Biotech Co currently.

The Eulerpool Quality Score for Syngen Biotech Co is 5/10.

The ISIN of Syngen Biotech Co is TW0008279001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Syngen Biotech Co is 8279.TWO. The ticker symbol is used to trade Syngen Biotech Co shares on the stock exchange.

Fair ValueTerminal
83.51 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Nov 14, 2014
ISIN
TW0008279001
Cusip
Y8320M126
Market capitalization
2.18 B TWDMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
5.64
P/B Ratio
0.92
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.42 %
Dividend
Dividend yield
6.23 %
Payout Ratio
49.89 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
4 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Nov 10, 2026, 3:45 AM

Syngen Biotech Co Peer Group

Syngen Biotech Co FIGI

8279:TT (Taipei Stock Exchange) · BBG007H158Y3